$38.59
0.090.23%
Últ. Act.: Oct 29, 4:00 PM
Harmony Biosciences Hldgs (HRMY) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Harmony Biosciences Hldgs (HRMY) publicó su última previsión de agosto 4, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $1B - $1.04B para el período.
En comparación con la previsión anterior, Harmony Biosciences Hldgs mantenido redujo su previsión de ingresos desde un rango anterior de $1B - $1.04B.
Harmony Biosciences Hldgs ha emitido 23 actualizaciones de orientación entre el enero 8, 2024 y el agosto 4, 2026. During this period, the company raised its outlook 4 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.05 | $0.90 | $0.98 | $0.88 |
| Actual | $1.28 | $0.55 | $0.57 | $1.08 |
| Surprise | +21.9% | -38.9% | -41.8% | +22.7% |
| Revenue | ||||
| Estimate | $242.1M | $221.2M | $241.5M | $225.2M |
| Actual | $261.3M | $215.4M | $243.8M | $239.5M |
| Surprise | +7.91% | -2.61% | +0.95% | +6.33% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.37 | $1.42 | $0.83 | $0.98 |
| Revenue | ||||
| Consensus | $273.2M | $281.4M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $1.28 | $1.05 | 21.9 % |
| Q1 | May 7, 2026 | $0.55 | $0.90 | -38.9 % |
| Q4 | Feb 24, 2026 | $0.57 | $0.98 | -41.8 % |
| Q3 | Nov 4, 2025 | $1.08 | $0.88 | 22.7 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $261.30M | $242.15M | 7.91 % |
| Q1 | May 7, 2026 | $215.40M | $221.17M | -2.61 % |
| Q4 | Feb 24, 2026 | $243.78M | $241.47M | 0.95 % |
| Q3 | Nov 4, 2025 | $239.46M | $225.19M | 6.33 % |